A novel peptide from human apolipoprotein(a) inhibits angiogenesis and tumor growth by targeting c-Src phosphorylation in VEGF-induced human umbilical endothelial cells.
about
Cucurbitacin E, a tetracyclic triterpenes compound from Chinese medicine, inhibits tumor angiogenesis through VEGFR2-mediated Jak2-STAT3 signaling pathway.Indirubin inhibits tumor growth by antitumor angiogenesis via blocking VEGFR2-mediated JAK/STAT3 signaling in endothelial cell.Low lipoprotein(a) concentration is associated with cancer and all-cause deaths: a population-based cohort study (the JMS cohort study).A natural small molecule harmine inhibits angiogenesis and suppresses tumour growth through activation of p53 in endothelial cells.Apolipoprotein(a) inhibits in vitro tube formation in endothelial cells: identification of roles for Kringle V and the plasminogen activation systemAnti-angiogenic peptides for cancer therapeuticsProteomics approaches for identification of tumor relevant protein targets in pulmonary squamous cell carcinoma by 2D-DIGE-MS.Kisspeptin-10, a KISS1-derived decapeptide, inhibits tumor angiogenesis by suppressing Sp1-mediated VEGF expression and FAK/Rho GTPase activationPlumbagin inhibits tumour angiogenesis and tumour growth through the Ras signalling pathway following activation of the VEGF receptor-2The Chick Embryo Chorioallantoic Membrane as an In Vivo Assay to Study Antiangiogenesis.Cucurbitacin E inhibits breast tumor metastasis by suppressing cell migration and invasion.Studies on the anti-angiogenic effect of Marsdenia tenacissima extract in vitro and in vivoLGR4 modulates breast cancer initiation, metastasis, and cancer stem cells.Apolipoprotein A-I Is a Prognosticator of Nasopharyngeal Carcinoma in the Era of Intensity-modulated Radiotherapy.Inhibition of ocular neovascularization by a novel peptide derived from human placenta growth factor-1.Usnic acid inhibits breast tumor angiogenesis and growth by suppressing VEGFR2-mediated AKT and ERK1/2 signaling pathways.Using a Classifier Fusion Strategy to Identify Anti-angiogenic Peptides
P2860
Q34132787-A919BA3E-1665-4177-915C-DD4A6BE375A2Q34157601-BB04870B-D4A3-4744-AD0D-BE87FE4CD3E2Q34224722-5DEF902C-FF91-403C-BEC3-2F8C0488ABF1Q34540424-D24391D9-5AD7-497C-9D3C-0D19EBF38543Q34550920-292AB269-C282-4081-BD7B-D966E72D8456Q35043016-20E8EBB6-6DC3-4659-938F-CEB7102CBCDBQ35150432-871E0BB1-837E-490D-83D3-E6D267AB5688Q35622038-2C3F4F2C-61DC-4356-A60E-48C9D0672FBEQ35940368-A5761C8A-C2CB-4516-8E4A-2D8D6E2124F3Q38974193-FE46BCEC-F3E0-4BA9-8460-39D3C22CF60BQ39306606-8397D838-583B-4CBD-AFB8-A2E84DC662E3Q41931764-0AFBC2D9-DE5B-4D53-9CF9-76F5FB98EE51Q47561597-E3A9EAAD-16FF-48CF-B72A-215F0BA82680Q54252946-09265630-5DB3-4676-A2C6-A7FF97A60AF4Q54482424-76CDDD33-7622-4AF2-ADE3-9628CAF6768DQ54506451-4990554C-2339-4152-B6EF-7ACD72DBC40EQ58740632-1825091A-0D72-4133-9733-F2A344CAD876
P2860
A novel peptide from human apolipoprotein(a) inhibits angiogenesis and tumor growth by targeting c-Src phosphorylation in VEGF-induced human umbilical endothelial cells.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on February 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
A novel peptide from human apolipoprotein
@nl
A novel peptide from human apo ...... n umbilical endothelial cells.
@en
type
label
A novel peptide from human apolipoprotein
@nl
A novel peptide from human apo ...... n umbilical endothelial cells.
@en
prefLabel
A novel peptide from human apolipoprotein
@nl
A novel peptide from human apo ...... n umbilical endothelial cells.
@en
P2093
P2860
P356
P1476
A novel peptide from human apo ...... n umbilical endothelial cells.
@en
P2093
Mingyao Liu
Sung-Gook Cho
Tingfang Yi
Yuan-Yuan Wu
Zheng-Fang Yi
P2860
P304
P356
10.1002/IJC.24027
P577
2009-02-01T00:00:00Z